ARISE-HIV LAUNCH Challenge
The ARISE-HIV LAUNCH Challenge supports teams developing practical ideas and implementation plans to expand the use of long-acting HIV prevention and treatment for underserved people in the United States.
Funder: NIH Challenges
Due Dates: August 6, 2026 (Phase 1) | February 15, 2027 (Phase 2, estimated)
Funding Amounts: $1 million prize pool; up to 35 Phase 1 prizes of $10,000 and 13 Phase 2 prizes of $50,000
Summary: Cash prizes reward practical ideas and implementation plans that improve the use of long-acting HIV prevention and treatment in the United States.
Key Information: Only Phase 1 winners may compete in Phase 2.
Description
The NIH Office of AIDS Research sponsors this prize challenge through its Advancing Research in Implementation Science to End HIV (ARISE-HIV) program. It seeks actionable ways to overcome barriers to the adoption and scale-up of long-acting HIV prevention and treatment products in the United States. Ideas may address access, service delivery, engagement, or retention across health systems and communities.
Phase 1 rewards feasible, innovative concepts; Phase 2 rewards plans to implement and evaluate winning concepts. The challenge favors approaches that can work in real-world settings, reach people whose needs have not been met by existing options, and potentially extend beyond a single setting or population.
